Following interim results earlier this week, we’re taking the opportunity to update numbers to account for a variety of variables including currency, market backdrop/peer group and investment phasing. We think R&D costs – primarily associated with the ground-breaking US development programme for Pollinex Quattro Grass – will likely dig deeper particularly in FY17E, but increased investment in commercial infrastructure will see accelerated top line growth. Given the marke
